High Potency APIs Market Size and Forecasts (2021 - 2031), Global and Regional Share, Trends, and Growth Opportunity Analysis

Coverage: High Potency APIs Market covers analysis by Type (Generic and Innovative), Type of Synthesis (Synthetic and Biotech), Manufacturer (In-House and Outsourced), and Therapeutic Application (Oncology, Hormonal Imbalance, Glaucoma, and Others), and Geography (North America, Europe, Asia Pacific, and South and Central America)

Publication Month : Mar 2024

  • Report Code : TIPRE00003533
  • Category : Pharmaceuticals
  • Status : Upcoming
  • No. of Pages : 150
Inquire Before Buy

PRICING

$5190

$4671

The high potency APIs market is expected to grow from US$ 22.74 billion in 2021 to US$ 42.65 billion by 2028; it is expected to grow at a CAGR of 9.4% from 2022 to 2028.

The high potency active pharmaceutical ingredients are highly effective even in small amount. The  HPAPIs target specific abnormal cells and destroys them. Hence, they are used in the drugs prescribed for the treatment of chronic diseases.  The importance of API manufacturers in the pharmaceutical industry is changing as a result of new customer demands and increasing pressures from global competitors, which is offering lucrative opportunities for the market. With regard to entrance obstacles, regulatory constraints, large investments, and knowledge-related to APIs and HPAPI development, manufacturers with different experiences are making significant investments in HPAPI capabilities.

MARKET DYNAMICS

The growth of the high potency APIs market is majorly attributed to the growing demand for antibody-drug conjugates, rising prevalence of cancer, increasing focus of leading pharmaceutical companies on HPAPIs, advancements in HPAPI manufacturing technologies, and growing focus on precision medicine. Moreover, the growing adoption of HPAPI in different applications and the high growth in cancer therapeutics would supplement market growth during the forecast period. However, dearth of skilled professionals is hampering the growth of the market.

MARKET SCOPE

The “Global High Potency APIs market Forecast to 2028” report aims to provide an overview of the high potency APIs ( market with detailed market segmentation based on type, type of synthesis, manufacturer, and therapeutic application. The report provides key market statistics based on the performances of the leading players. It also offers key trends and opportunities in the market.

Strategic Insights
MARKET SEGMENTATION

The global high potency APIs market is segmented on the basis of type, type of synthesis, manufacturer, and therapeutic application. Based on type, the market is bifurcated into generic and innovative. Based on type of synthesis, the market is segmented into synthetic and biotech. Based on manufacturer, the high potency APIs ( market Is segmented into in-house and outsourced. By therapeutic application, the market is segmented into oncology, hormonal imbalance, glaucoma, and others.


RD Image
  • Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
  • Request discounts available for Start-Ups & Universities
REGIONAL FRAMEWORK

The global high potency APIs market is segmented into five major regions—North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America. The report covers analysis and forecast of 18 countries across the world along with trends and opportunities prevailing in the region. From the regional perspective, North America dominated the market with ~35% share in 2021. The market growth in the region is majorly attributed to the presence of prominent manufacturers and advanced technological infrastructure. Additionally, the high prevalence of chronic diseases, such as cancers, in the region is driving the market growth. The below figure shows the revenue growth trend in the global high potency APIs ( market:

High Potency APIs MarketSource: The Insight Partners Analysis

The report analyzes factors, such as drivers, restraints, opportunities, and future trends, which impact the high potency APIs market. It also provides an exhaustive Porter's five forces analysis of the factors influencing the market.

IMPACT OF COVID-19 PANDEMIC

The high-potency APIs/HPAPI market suffered during the COVID-19 pandemic due to disrupted supply chain. China and India are the two countries where most API is produced. In 2020, according to the Germany Trade & Invest (GTAI), around 60% of the world's APIs, particularly high-potency APIs, are made in China or India, and 18% of the generic medicine production market worldwide is accounted for by India alone. The majority of this produced medicines are exported to other nations. Also, 70% of India's generics industry's APIs, particularly high-potency APIs, are produced in China, a significant manufacturing hub. These countries were the most affected by the pandemic, which hindered the market growth. However, due to rising cases of COVID-19, and many countries approved the use of antiviral drugs with high potency molecules. For example, remdesivir has been approved for COVID-19 treatment. The overall high-potency APIs/HPAPI market was adversely affected during the COVID-19 Pandemic.

World Geography

Have a question?

Analyst

Akshay

Akshay will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.

Analyst   Speak to Analyst
  • Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
  • Request discounts available for Start-Ups & Universities
MARKET PLAYERS

The report covers key developments in the high potency APIs market. Various companies are focusing on organic growth strategies, such as product launches, product approvals, patents, and events. Inorganic growth strategies such as acquisitions, partnerships, and collaborations have encouraged the expansion of business and the customer base of market players. The market players are anticipated to experience lucrative growth opportunities in the coming years due to the rising demand for high potency APIs ( products.

The report also includes the profiles of key high potency APIs market companies, along with their SWOT analysis and market strategies. In addition, it focuses on leading industry players’ information such as company profiles, components and services offered, financial information for the last three years, and key development in the past five years. The list of a few companies engaged in the high potency APIs ( market is mentioned below:

  •   Pfizer Inc
  •   F Hoffmann La Roche Ltd
  •   Eli Lilly and Company
  •   Bristol Myers Squibb Company
  •   Novartis AG
  •   Sanofi
  •   Merck Sharp and Dohme Corp
  •   Bayer AG
  •   AbbVie
  •   Teva Pharmaceutical Industries Ltd

The Insight Partner's dedicated research and analysis team consists of experienced professionals with advanced statistical expertise and offers various customization options in the existing study.


Market Research

  • Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
  • Request discounts available for Start-Ups & Universities
Report Coverage
Report Coverage

Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends

Segment Covered
Segment Covered

Type, Type of Synthesis, Manufacturer, and Therapeutic Application

Regional Scope
Regional Scope

North America, Europe, Asia Pacific, Middle East & Africa, South & Central America

Country Scope
Country Scope

US, UK, Canada, Germany, France, Italy, Australia, Russia, China, Japan, South Korea, Saudi Arabia, Brazil, Argentina

The List of Companies

  1. Pfizer Inc
  2. F Hoffmann La Roche Ltd
  3. Eli Lilly and Company
  4. Bristol Myers Squibb Company
  5. Novartis AG
  6. Sanofi
  7. Merck Sharp and Dohme Corp
  8. Bayer AG
  9. AbbVie
  10. Teva Pharmaceutical Industries Ltd
  11. Lonza
  12. Boehringer Ingelheim International GmbH
  13. Janssen Pharmaceuticals, Inc
  14. Dr. Reddy's laboratories

The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.

  1. Data Collection and Secondary Research:

As a market research and consulting firm operating from a decade, we have published many reports and advised several clients across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.

Several associations trade associates, technical forums, institutes, societies and organizations are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in the last 3 years are scrutinized and analyzed to understand the current market trends.

  1. Primary Research:

The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.

For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/Sales Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.

A typical research interview fulfils the following functions:

  • Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
  • Validates and strengthens in-house secondary research findings
  • Develops the analysis team’s expertise and market understanding

Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:

  • Industry participants: VPs, business development managers, market intelligence managers and national sales managers
  • Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.

Below is the breakup of our primary respondents by company, designation, and region:

Research Methodology

Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.

  1. Data Analysis:

Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.

  • 3.1 Macro-Economic Factor Analysis:

We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.

  • 3.2 Country Level Data:

Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.

  • 3.3 Company Profile:

The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.

  • 3.4 Developing Base Number:

Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.

  1. Data Triangulation and Final Review:

The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.

We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.

We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.

Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Trends and growth analysis reports related to High Potency APIs Market